2021
DOI: 10.7759/cureus.12791
|View full text |Cite
|
Sign up to set email alerts
|

Asymptomatic HyperCKemia: A Diagnostic Trap

Abstract: Elevated creatine kinase (CK) levels are the most sensitive indicator of muscle injury. Levels >5000 U/L warns physicians to initiate aggressive hydration and prevent renal failure. We present a rare case of asymptomatic hyperCkemia with levels >80 times the upper limit of normal (ULN), refractory to fluid resuscitation. Our patient was found to have elevated macroenzymes- macroCkemia, causing decreased clearance of CK. The objective of this case report is to bring to attention a rare and benign cause of CK el… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 8 publications
0
0
0
Order By: Relevance
“…In 2023, brexpiprazole, widely prescribed for schizophrenia and major depressive disorder, became the first US Food and Drug Administration-approved treatment for agitation in Alzheimer dementia. 3 This marks a promising, effective, and well-tolerated option for individuals with BPSD. 3,4 In this case, we document a patient diagnosed with dementia with Lewy bodies (DLB) and accompanying BPSD and agitation, managed with the use of brexpiprazole during admission.…”
mentioning
confidence: 99%
See 3 more Smart Citations
“…In 2023, brexpiprazole, widely prescribed for schizophrenia and major depressive disorder, became the first US Food and Drug Administration-approved treatment for agitation in Alzheimer dementia. 3 This marks a promising, effective, and well-tolerated option for individuals with BPSD. 3,4 In this case, we document a patient diagnosed with dementia with Lewy bodies (DLB) and accompanying BPSD and agitation, managed with the use of brexpiprazole during admission.…”
mentioning
confidence: 99%
“…3 This marks a promising, effective, and well-tolerated option for individuals with BPSD. 3,4 In this case, we document a patient diagnosed with dementia with Lewy bodies (DLB) and accompanying BPSD and agitation, managed with the use of brexpiprazole during admission.…”
mentioning
confidence: 99%
See 2 more Smart Citations